Do chronic high-frequency deep-brain stimulation in progressive myoclonic epilepsy in adulthood -- report of five cases?
DBS of the SNr/STN may be an effective treatment option for patients with PME. Less impaired patients may benefit more markedly.
These results showed that CPEE can protect against allergic airway inflammation and can act as an MMP-9 modulator to induce a reduction in ICAM-1 and VCAM-1 expression. In conclusion, we strongly suggest the feasibility of CPEE as a therapeutic drug for allergic asthma.